1Schofield RS, Kline SE, Schmalfuss CM, et al. Early outcomes of a care coordination - enhanced telehome care program for elderly veterans with chronic heart failure [ J]. Telemed J E Health, 2005, 11 ( 1 ) :20 - 27.
2Ishani A, Weinhandl E, Zhao Z, et al. Angiutensin - converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction [J]. J Am Coil Cardiol, 2005, 45 (3) : 391 -399.
3Shao Q, Ren B, Saini HK, et al. Sarcoplasmic reticulum Ca^2+ transport and gene expression in congestive heart failure are modified by imidapril treatment [ J ]. Am J Physiol Heart Circ Physiol, 2005, 288(4): 1674 -1682.
4Srinivasan J, Jayadev S, Kumaran D, et al. Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension[J]. Ndian J Exp Biol, 2005, 43 (3) : 241 -246.
5Barnett AH. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study [ J].Acta Diabetol, 2005, 42 (Suppl 1): 42-49.
6Winer N, Folker A, Murphy JA, et al. Effect of fixed - dose ACE -inhibitor/calcium channel blocker combination therapy vs. ACE - inhibitor monotherapy on arterial compliance in hypertensive patients with type2 diabetes [J]. Prey Cardiol, 2005, 8 (2): 87-92.
7Da Cunha V, Tham DM, Martin McNulty B, et al. Enalapril attenuates angiotensin Ⅱ - induced atherosclerosis and vascular inflammation[J]. Atherosclerosis, 2005, 178 (1): 9-17.
8Manning J, Vehaskari VM. Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition [J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288 ( 1 ) : 80 -84.